Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The primary objective is to evaluate the safety and efficacy of divalproex extended release (ER) compared to risperidone in the treatment of bipolar disorder with comorbid substance use disorder
Epistemonikos ID: 716ac34e7aa88c00a12f1f850c50758a75e67d3d
First added on: May 04, 2024